Researchers found that nearly all major DNA methylation changes were associated with tau accumulation rather than amyloid plaques.
Under the new system, Emiratis will be able to access healthcare services anywhere in the country regardless of their emirate of residence.
The at-home model integrates medical-grade care into everyday living, allowing patients to receive treatment in a private environment while still benefiting from hospital-level standards.
Under the new framework, Arcera Life Sciences will collaborate with M42 to harness genomics data and explore disease prevalence patterns across targeted genetic and rare conditions.
The hospital introduced the technology as part of its broader strategy to expand minimally invasive surgical options and align with global standards in clinical care.
The plan follows Arada’s acquisition of a controlling stake in Reem Hospital, marking the company’s entry into the healthcare sector as it expands its presence across non-residential industries.
Alzheimer’s disease is characterized by the accumulation of tau protein in the brain, which gradually damages nerve cells and impairs memory and cognitive function.
Wegovy® pill is the first oral glucagon-like peptide-1 (GLP-1) receptor agonist approved for weight management.
The innovation aims to enhance fluid drainage, speed up recovery, and potentially reduce the need for additional corrective procedures.
Researchers aim to assess the reliability of p-Tau217 in identifying early Alzheimer’s pathology and evaluate its potential as a scalable tool for long-term monitoring.